← Back to catalogue

Acceava®

FDA UDI

Class I (US FDA UDI)

by Alere San Diego, Inc.

Identity

Trade Name
Acceava® FDA UDI
Generic Name
Beta-haemolytic Group A Streptococcus antigen IVD, kit, rapid ICT, clinical FDA UDI
Device Name
Alere Acceava™ Strep A FDA UDI
Model / Reference
92001 FDA UDI
Description
Alere Acceava™ Strep A FDA UDI

Identifiers

Catalog Number
4580295008 FDA UDI
Primary DI / UDI-DI
10815845020031 FDA UDI
FDA Product Code
GTY FDA UDI
GMDN Term
Beta-haemolytic Group A Streptococcus antigen IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
866.3740 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Beta-haemolytic Group A Streptococcus antigen IVD, kit, rapid ICT, clinical

Acceava® by Alere San Diego, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Beta-haemolytic Group A Streptococcus antigen IVD, kit, rapid ICT, clinical.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 53193335-1dbf-40ac-89ba-1d03712dc4c3 35 fields · synced Jun 9, 2026